Enforcement Gaps in Regulatory Data Protection Rights in the EU
This article was originally published in SRA
Executive Summary
Maarten Meulenbelt argues that until the European Union addresses shortfalls in the enforcement of regulatory data protection rights, it cannot claim that it values innovation and intellectual property rights in the pharmaceutical industry.